Clinical Trial Update: A Study of IBI362 in Chinese Adolescents With Obesity or Overweight [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the obesity treatment candidate IBI362 in adolescents; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• IBI362

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Adolescents With Obesity or Overweight With Weight-Related Comorbidities | Phase 3 | Status: RECRUITING